Manuel S. Eisenberg
- Sep 27, 2020
- 1 min read

Finasteride/Dutasteride do not increase the risk of depression

Finasteride and dutasteride are 2 common medications for the long-term treatment of an enlarged prostate. There has been some concern that these medications increase the risk of depression, however a recent study evaluating over 53,000 men saw no increased risk. Instead, depression may be due to a man's underlying urinary symptoms and could be an indication that surgical interventions such as UroLift or TURP should be considered.

https://www.auajournals.org/doi/10.1097/JU.0000000000001079

Recent Posts

See All

UroLift continues to do well in "real world" studies

Results of UroLift were evaluated in a group of 2000 patients. Of these patients, 153 required some type of intervention during follow up. The overall reintervention rate was calculated at 6% per ye

Sexual function is a significant consideration when undergoing treatment for BPH

The majority of men over 50 years old have some degree of urinary symptoms due to an enlarge prostate. Both medications and surgery for the treatment of these symptoms can have side effects, includin

UroLift performs better than Rezume in the “real world”

A recent study compared the early outcomes of UroLift (prostatic urethral lift) versus Rezume (prostate steam therapy) in patients in the community/”real work” setting. The early outcomes show superi